Insider · CIK 0001856094

Borgeson Blake

Reports to the SEC for 1 company · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001856094

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−50K sh	$4.84	−$242K	6,108,287
2026-09-01	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$3.34	−$100K	6,158,287
2026-08-04	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$3.25	−$97.5K	6,188,287
2026-07-07	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−40K sh	$3.96	−$159K	6,218,287
2026-06-17	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+88.4K sh	—	—	6,258,287
2026-06-02	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$3.68	−$110K	6,169,863
2026-05-05	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$3.52	−$106K	6,199,863
2026-04-07	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−30K sh	$3.10	−$93K	6,229,863
2026-03-03	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−170K sh	$3.46	−$588K	6,259,863
2026-02-03	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−220K sh	$4.20	−$924K	6,429,863
2026-01-06	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−220K sh	$4.36	−$959K	6,649,863
2025-12-02	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−220K sh	$4.37	−$961K	6,869,863
2025-06-18	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+44K sh	—	—	44,031
2025-06-18	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+22K sh	—	—	7,089,863
2025-01-02	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,734 sh	—	—	7,067,847
2024-11-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.64	−$87.5K	7,066,113
2024-10-29	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.72	−$76.9K	7,077,560
2024-10-15	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.67	−$76.3K	7,089,007
2024-10-01	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.22	−$71.1K	7,098,428
2024-10-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+2,026 sh	—	—	7,100,454
2024-09-17	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.84	−$78.3K	7,109,875
2024-09-03	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.27	−$71.7K	7,121,322
2024-08-20	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.12	−$81.5K	7,132,769
2024-08-06	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.82	−$78.1K	7,144,216
2024-07-23	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$8.48	−$97K	7,155,663
2024-07-09	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.32	−$83.7K	7,167,110
2024-07-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,441 sh	—	—	7,178,557
2024-06-25	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$9.51	−$109K	7,177,116
2024-06-11	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$8.45	−$96.8K	7,188,563
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+26.2K sh	—	—	26,193
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+13.1K sh	—	—	7,200,010
2024-05-28	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$9.17	−$105K	7,186,913
2024-05-14	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−20.1K sh	$10.12	−$203K	7,198,360
2024-04-30	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.95	−$91K	7,218,414
2024-04-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.66	−$87.7K	7,229,861
2024-04-02	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$8.82	−$101K	7,241,308
2024-03-19	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−20.1K sh	$10.79	−$216K	7,252,755
2024-03-05	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−20.1K sh	$12.06	−$242K	7,272,809
2024-02-20	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−19.7K sh	$12.31	−$243K	7,293,172
2024-02-20	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−309 sh	$13.04	−$4,030.349	7,292,863
2024-02-06	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$9.30	−$106K	7,312,917
2024-01-23	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−20.1K sh	$10.58	−$212K	7,324,364
2024-01-09	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,303 sh	$13.21	−$83.3K	7,358,169
2024-01-09	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−13.8K sh	$13.81	−$190K	7,344,418
2023-12-26	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−20.1K sh	$10.63	−$213K	7,364,472
2023-12-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$7.40	−$84.7K	7,384,526
2023-11-28	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.4K sh	$6.72	−$76.9K	7,395,973
2023-11-14	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,885 sh	$6.32	−$56.2K	7,407,420
2023-10-31	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,885 sh	$5.27	−$46.9K	7,416,305
2023-10-17	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,885 sh	$6.58	−$58.5K	7,425,190

Recent filings

Accepted (ET)
Oct 7 18:084
Borgeson Blake0001601830-26-000120
SEC(opens sec.gov)
Sep 24
Borgeson Blake0001601830-26-000103
SEC(opens sec.gov)
Aug 64
Borgeson Blake0001856094-26-000014
SEC(opens sec.gov)
Jul 94
Borgeson Blake0001856094-26-000011
SEC(opens sec.gov)
Jun 224
Borgeson Blake0001601830-26-000088
SEC(opens sec.gov)
Jun 44
Borgeson Blake0001856094-26-000008
SEC(opens sec.gov)
May 74
Borgeson Blake0001856094-26-000005
SEC(opens sec.gov)
Apr 84
Borgeson Blake0001856094-26-000003
SEC(opens sec.gov)
Mar 44
Borgeson Blake0001601830-26-000045
SEC(opens sec.gov)
Feb 64
Borgeson Blake0001601830-26-000007
SEC(opens sec.gov)
Jan 84
Borgeson Blake0001856094-26-000002
SEC(opens sec.gov)
Dec 44
Borgeson Blake0001856094-25-000006
SEC(opens sec.gov)
Jun 234
Borgeson Blake0001601830-25-000112
SEC(opens sec.gov)
Jan 64
Borgeson Blake0001601830-25-000004
SEC(opens sec.gov)
Nov 144
Borgeson Blake0001601830-24-000205
SEC(opens sec.gov)
Oct 314
Borgeson Blake0001601830-24-000186
SEC(opens sec.gov)
Oct 174
Borgeson Blake0001601830-24-000179
SEC(opens sec.gov)
Oct 44
Borgeson Blake0001601830-24-000174
SEC(opens sec.gov)
Oct 34
Borgeson Blake0001601830-24-000166
SEC(opens sec.gov)

Companies

RECURSION PHARMACEUTICALS, INC.DirectorRXRX

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101